Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.
about
Tissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaDevelopments in the identification of glycan biomarkers for the detection of cancerLow serum levels of alpha1 anti-trypsin (α1-AT) and risk of airflow obstruction in non-primary α1-AT-deficient patients with compensated chronic liver diseaseFBG1 Is the Final Arbitrator of A1AT-Z Degradationα1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expressionMass-selected site-specific core-fucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma.Challenges to developing proteomic-based breast cancer diagnostics.N-glycans in liver-secreted and immunoglogulin-derived protein fractions.Uromodulin and α(1)-antitrypsin urinary peptide analysis to differentiate glomerular kidney diseases.Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver diseaseProtein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populationsERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC)Cell surface glycan alterations in epithelial mesenchymal transition process of Huh7 hepatocellular carcinoma cell.Gene expression profiling of MYC-driven tumor signatures in porcine liver stem cells by transcriptome sequencing.Development of recombinant Aleuria aurantia lectins with altered binding specificities to fucosylated glycans.Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cellsTwo-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry.Increased levels of tetra-antennary N-linked glycan but not core fucosylation are associated with hepatocellular carcinoma tissueTotal serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma.Differential N-Glycosylation Patterns in Lung Adenocarcinoma TissueA novel core fucose-specific lectin from the mushroom Pholiota squarrosa.Snail and serpinA1 promote tumor progression and predict prognosis in colorectal cancerReverse lectin ELISA for detecting fucosylated forms of α1-acid glycoprotein associated with hepatocellular carcinoma.A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum GlycoproteinsSecretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells.The Doylestown Algorithm: A Test to Improve the Performance of AFP in the Detection of Hepatocellular CarcinomaSite-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinomaIntrinsic hepatocyte dedifferentiation is accompanied by upregulation of mesenchymal markers, protein sialylation and core alpha 1,6 linked fucosylationIncreased sialylation of site specific O-glycoforms of hemopexin in liver disease.Discrimination between adenocarcinoma and normal pancreatic ductal fluid by proteomic and glycomic analysis.Human urine proteomics: building a list of human urine cancer biomarkers.Acute phase glycoproteins: bystanders or participants in carcinogenesis?Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinomaQuantitative mass spectrometric analysis of glycoproteins combined with enrichment methods.Glycosylation and liver cancer.Clinical diagnostics and therapy monitoring in the congenital disorders of glycosylationAlpha-1-Antitrypsin Antagonizes Cisplatin-Induced Cytotoxicity in Prostate Cancer (PC3) and Melanoma Cancer (A375) Cell Lines.A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.Identification of IgM as a contaminant in lectin-FLISA assays for HCC detection.A procedure for the analysis of site-specific and structure-specific fucosylation in alpha-1-antitrypsin.
P2860
Q26743361-E2F8A3BF-39BA-4F4C-AE89-2BC46AF82F3CQ27026715-BB24CF34-584B-490C-B847-A4F9B6540E0CQ28393624-04C7A009-A041-4EC5-A624-C9B224FC9569Q28547422-DD1CC1C8-6087-4E32-8B3E-1729BF18B0CDQ33699457-B8C4FAB6-3FDE-4C75-98D2-D23BA7012CE4Q33761846-2DD53149-2C9C-4851-A0DE-8B29BA3A9247Q33823926-F636BFC4-0E9F-472B-AFAA-18DE765B86E4Q34156760-A884673A-D65B-41B7-916B-597ADEEDCDDAQ34187912-DD128F40-74A0-46A2-B50F-F4F2BE32E453Q34464343-A0412295-6142-4D36-A899-8D834BD08EC3Q34918154-D2193379-9E05-43BF-BF00-0B0A7BABDD0CQ34938492-1E32B49C-0169-4797-8A2D-756792228A59Q34970766-AF5F80A5-D506-4072-AC3A-495006F3D063Q35078001-A544EACB-4D55-44B0-A8A5-F77E62DF1FCAQ35450855-5F738156-14D4-4DB4-BD1E-E7BC6F3A5920Q35640704-80388CFC-BBBF-42A4-904B-4A410E4AF334Q35821161-6CA08FE5-5C26-44B7-9D49-71FD9083B432Q36051363-37CE8953-4518-48AB-9A6E-1E908467AFF5Q36155480-6F60601B-7B17-4C8A-89F1-FEE175112952Q36278033-18F646C6-2FCA-4366-8EC6-7C8C22B07AAAQ36298291-4CB512E1-C88F-4B40-996A-C0D2A088CBF2Q36299674-CB551E66-2022-478B-B152-0F250BC1F9F0Q36309104-F6EB5826-5C97-4377-8B13-11BD1B950519Q36348802-6601E9CF-F889-4284-AA06-C322DF9A43EAQ36386977-A39E5C19-DD8E-49D2-B286-AD091B8FDAE1Q36540674-A7A14258-087A-4FDD-BB4C-52D430F7903DQ36832489-5BB137E4-A398-4E2E-818F-79DFA498011EQ37027426-AD07D869-A09A-4B33-B3F0-0833CFFC784AQ37278723-50676C38-099F-4FDA-9245-5A9ACC3B9EC2Q37624230-6E9EFA64-F83B-46C9-A47A-77554DCFB68AQ37890422-8C5FC8F4-3C65-4C38-B842-611A12C2F7A3Q37986822-55925B58-5B8B-46A5-B366-6B65138AC82FQ38060725-8986146F-D927-4ACC-9DD1-5534275B0694Q38217009-67D22732-0EBC-40EA-8900-61BDAF0C7A2CQ38366329-DC392F33-EE4C-4C74-954D-1DD171128563Q38688788-2DE28836-63FC-4020-AA20-E84B0592A47DQ38746895-49DE590C-4D12-44CA-A625-C147D53EB09BQ38847018-55B6CE5C-079D-4FC7-B519-9FFAB6D780CBQ41479549-12A196A0-2398-4D36-8E2B-24C25D1BA46EQ41640544-796F4CC1-342B-447B-903E-399854C7D416
P2860
Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Linkage specific fucosylation ...... r of hepatocellular carcinoma.
@ast
Linkage specific fucosylation ...... r of hepatocellular carcinoma.
@en
type
label
Linkage specific fucosylation ...... r of hepatocellular carcinoma.
@ast
Linkage specific fucosylation ...... r of hepatocellular carcinoma.
@en
prefLabel
Linkage specific fucosylation ...... r of hepatocellular carcinoma.
@ast
Linkage specific fucosylation ...... r of hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
Linkage specific fucosylation ...... r of hepatocellular carcinoma.
@en
P2093
Anand Mehta
Julie Hafner
Lucy Rodemich-Betesh
Mary Ann Comunale
Mengjun Wang
Timothy Block
P2860
P304
P356
10.1371/JOURNAL.PONE.0012419
P407
P577
2010-08-25T00:00:00Z